26/06/2019 17:31:38

Legal Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – AGN, DFRG, PCMI, RTEC

NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating Allergan plc (NYSE: AGN), Del Frisco’s Restaurant Group, Inc. (NASDAQ: DFRG), PCM, Inc. (NASDAQ: PCMI), and Rudolph Technologies, Inc. (NYSE: RTEC) in connection with the sale of these respective companies. On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Allergan plc (NYSE: AGN)

The investigation concerns whether Allergan and/or its Board of Directors breached their fiduciary duties and/or violated the federal securities laws in connection with the proposed sale of Allergan to AbbVie Inc. for 0.8660 AbbVie shares and $120.30 in cash for each Allergan share. To learn more about the Allergan investigation and your legal rights and options, please visit: https://halpersadeh.com/actions/allergan-plc-agn-stock-merger-abbvie/.

Del Frisco’s Restaurant Group, Inc. (NASDAQ: DFRG)

The investigation concerns whether Del Frisco’s and/or its Board of Directors breached their fiduciary duties and/or violated the federal securities laws in connection with the proposed sale of Del Frisco’s to Catterton for $8.00 per share in cash. To learn more about the Del Frisco’s investigation and your legal rights and options, please visit: https://halpersadeh.com/actions/del-friscos-restaurant-group-inc-dfrg-merger-stock-l-catterton/.

PCM, Inc. (NASDAQ: PCMI)

The investigation concerns whether PCM and/or its Board of Directors breached their fiduciary duties and/or violated the federal securities laws in connection with the proposed sale of PCM to Insight Enterprises for $35.00 per share. To learn more about the PCM investigation and your legal rights and options, please visit: https://halpersadeh.com/actions/pcm-inc-pcmi-stock-merger-insight/.

Rudolph Technologies, Inc.

(NYSE: RTEC)

The investigation concerns whether Rudolph and/or its Board of Directors breached their fiduciary duties and/or violated the federal securities laws in connection with the proposed merger of Rudolph with Nanometrics Incorporated, for which Rudolph shareholders would receive 0.8042 shares of Nanometrics common stock for each Rudolph share. To learn more about the Rudolph investigation and your legal rights and options, please visit: https://halpersadeh.com/actions/rudolph-technologies-inc-rtec-merger-stock-nanometrics/.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

hsllp_logo.jpg

Related content
21 Aug - 
MERGER ALERT – ABDC, WAIR, and DFRG: Levi & Korsinsky, ..
20 Aug - 
Rigrodsky & Long, P.A. Files Class Action Suit Against ..
16 Aug - 
SHAREHOLDER ALERT: WeissLaw LLP Reminds TRCB, WAIR and ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
2
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
3
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
4
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
5
Ambu A/S: Interim report for Q3 2018/19

Related stock quotes

Del Frisco's Restaurant .. 7.970 -0.1% Stock price decreasing
PCM Inc 34.94 -0.1% Stock price decreasing
Rudolph Technologies Inc 23.60 3.2% Stock price increasing
Allergan PLC Ordinary Sh.. 161.25 1.3% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 11:05:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB4 - 2019-08-22 12:05:57 - 2019-08-22 11:05:57 - 1000 - Website: OKAY